BioSpace News Archive

Business

Expesicor receives SBIR award from the National Institutes of Health’s HEAL Initiative to develop an objective pain measurement tool

This technology is applicable to both personalized pain treatment and the development of novel pain management therapies, such as non-opioid medications.

November 11, 2019
·
3 min read
Deals

Sandoz Boosts Toehold in Japan with Aspen Acquisition

Novartis said the acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace.

November 11, 2019
·
2 min read
·
Alex Keown
Drug Development

ASLAN’s Varlitinib Fails Biliary Tract Cancer Trial

The drug failed to meet the primary endpoints of progression-free survival and overall response rate.

November 11, 2019
·
3 min read
·
Mark Terry
Deals

Foamix and Menlo Therapeutics Combine to Form Single Dermatology Company

The merged company will be led by David Domzalski, current chief executive officer of Foamix. It will be headquartered in New Jersey.

November 11, 2019
·
2 min read
·
Mark Terry
Business

Kaiser Permanente CEO Bernard Tyson, a Champion of Affordable Health Care, Dies Unexpectedly

Tyson served as CEO of Kaiser Permanente since 2013 and spent more than 30 years with the nonprofit healthcare giant.

November 11, 2019
·
3 min read
·
Alex Keown
Biotech Bay

Genentech Eyes Potential Approval of SMA Drug After Positive Trial Results

Genentech announced this morning that its experimental SMA drug risdiplam hit the mark in the second part of the pivotal SUNFISH study of patients with Type 2 and 3 of the disease.

November 11, 2019
·
3 min read
·
Alex Keown
Business

World AMR Congress: Fighting Anti-Microbial Resistance

The World Anti-Microbial Resistance Congress 2019 was held November 7-8 in Washington, D.C.

November 11, 2019
·
6 min read
·
Mark Terry
Drug Development

ACR Annual Meeting: Janssen’s Tremfya Nails Primary Endpoints in 24-Week Psoriatic Arthritis Studies

Both DISCOVER 1 and DISCOVER 2 are evaluating Tremfya in adults with active psoriatic arthritis.

November 11, 2019
·
4 min read
·
Mark Terry
Biotech Bay

Cofactor Genomics Opens Early Access to New T Cell Exhaustion Models through Predictive Immune Modeling Platform

Announces “Functional to FFPE” Early-Access Grant Program

November 11, 2019
·
3 min read
Deals

Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

Expedeon AG announces the signing of an agreement with Abcam plc, Cambridge, UK, to sell its proteomics and immunology business activities for a cash payment of EUR 120 million.

November 11, 2019
·
5 min read